Show simple item record

Author
dc.contributor.author
Firneisz, Gábor 
Author
dc.contributor.author
Rosta, Klara 
Author
dc.contributor.author
Al-Aissa, Zahra 
Author
dc.contributor.author
Hadarits, Orsolya 
Author
dc.contributor.author
Harreiter, Jürgen 
Author
dc.contributor.author
Nádasdi, Ákos 
Author
dc.contributor.author
Bancher-Todesca, Dagmar 
Author
dc.contributor.author
Németh, László 
Author
dc.contributor.author
Igaz, Péter 
Author
dc.contributor.author
Rigó, János 
Availability Date
dc.date.accessioned
2022-07-22T11:52:17Z
Availability Date
dc.date.available
2022-07-22T11:52:17Z
Release
dc.date.issued
2018
uri
dc.identifier.uri
http://hdl.handle.net/10831/67099
Language
dc.language
Angol

dc.rights
Nevezd meg! CC BY

dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
Title
dc.title
The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
Type
dc.type
folyóiratcikk
Date Change
dc.date.updated
2022-05-16T07:38:15Z
Note
dc.description.note
2nd Department of Internal Medicine, Semmelweis University, Budapest, H-1088, Hungary MTA-SE Molecular Medicine Research Group, Hungarian Academy of Sciences–Semmelweis University, Budapest, H-1088, Hungary Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, A-1090, Austria Department of Obstetrics and Gynecology, Semmelweis University, Budapest, H-1088, Hungary Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, A-1090, Austria Department of Probability Theory and Statistics, Eötvös Loránd University, Budapest, H-1088, Hungary Department of Obstetrics and Gynecology, Szent Imre Teaching Hospital, Budapest, H-1088, Hungary Cited By :1 Export Date: 20 December 2019 Correspondence Address: Firneisz, G.; 2nd Department of Internal Medicine, Semmelweis UniversityHungary; email: firneisz.gabor@med.semmelweis-univ.hu Összes idézések száma a WoS-ban: 0 2nd Department of Internal Medicine, Semmelweis University, Budapest, H-1088, Hungary MTA-SE Molecular Medicine Research Group, Hungarian Academy of Sciences–Semmelweis University, Budapest, H-1088, Hungary Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, A-1090, Austria Department of Obstetrics and Gynecology, Semmelweis University, Budapest, H-1088, Hungary Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, A-1090, Austria Department of Probability Theory and Statistics, Eötvös Loránd University, Budapest, H-1088, Hungary Department of Obstetrics and Gynecology, Szent Imre Teaching Hospital, Budapest, H-1088, Hungary Cited By :2 Export Date: 7 February 2020 Correspondence Address: Firneisz, G.; 2nd Department of Internal Medicine, Semmelweis UniversityHungary; email: firneisz.gabor@med.semmelweis-univ.hu Funding Agency and Grant Number: EFSD New Horizons Research Initiative grant Funding text: This study has been supported by the EFSD New Horizons Research Initiative grant. The article processing charges were covered by: the Hungarian Diabetes Association, Diabetologia and Metabolism Foundation, Budapest, Hungary and the Department of Internal Medicine III, Medical University of Vienna, Austria.
Doi ID
dc.identifier.doi
10.3390/ijms19123734
Wos ID
dc.identifier.wos
000455323500036
ID Scopus
dc.identifier.scopus
85057209385
MTMT ID
dc.identifier.mtmt
30325428
Issue Number
dc.identifier.issue
12
abbreviated journal
dc.identifier.jabbrev
INT J MOL SCI
Journal
dc.identifier.jtitle
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume Number
dc.identifier.volume
19
Release Date
dc.description.issuedate
2018
Pubmed ID
dc.identifier.pubmed
30477160
department of Author
dc.contributor.institution
MTA-SE Molekuláris Medicina Kutatócsoport
department of Author
dc.contributor.institution
Szülészeti és Nőgyógyászati Klinika
department of Author
dc.contributor.institution
I. Sz. Szülészeti és Nőgyógyászati Klinika
department of Author
dc.contributor.institution
II. Sz. Belgyógyászati Klinika
department of Author
dc.contributor.institution
Doktori Iskola
department of Author
dc.contributor.institution
Szülészeti és Nőgyógyászati Klinikai Ismeretek Tanszék
department of Author
dc.contributor.institution
Valószínűségelméleti és Statisztika Tanszék
department of Author
dc.contributor.institution
Rácz Károly Doktori Iskola
department of Author
dc.contributor.institution
Matematika Doktori Iskola
Author institution
dc.contributor.department
MTA-SE Molekuláris Medicina Kutatócsoport
Author institution
dc.contributor.department
II. Sz. Belgyógyászati Klinika
Author institution
dc.contributor.department
Szülészeti és Nőgyógyászati Klinika
Author institution
dc.contributor.department
II. Sz. Belgyógyászati Klinika
Author institution
dc.contributor.department
Szülészeti és Nőgyógyászati Klinika
Author institution
dc.contributor.department
II. Sz. Belgyógyászati Klinika
Author institution
dc.contributor.department
Valószínűségelméleti és Statisztika Tanszék
Author institution
dc.contributor.department
MTA-SE Molekuláris Medicina Kutatócsoport
Author institution
dc.contributor.department
II. Sz. Belgyógyászati Klinika
Author institution
dc.contributor.department
Szülészeti és Nőgyógyászati Klinika


Files in this item

The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
 

This item appears in the following Collection(s)

Show simple item record

Nevezd meg! CC BY
Except where otherwise noted, this item's license is described as Nevezd meg! CC BY